Trivalent M-related protein as a component of next generation group A streptococcal vaccines.

about

Population and Whole Genome Sequence Based Characterization of Invasive Group A Streptococci Recovered in the United States during 2015.Immune Cross-Opsonization Within emm Clusters Following Group A Streptococcus Skin Infection: Broadening the Scope of Type-Specific Immunity.

P2860

Q41676268-87A105F3-0ECC-487E-9DFE-1F78F6C3A12D Q47666939-8CBAFB9B-823B-4703-BD24-987435ABEDFE

P2860

Trivalent M-related protein as a component of next generation group A streptococcal vaccines.

Item

http://www.wikidata.org/entity/Q38760588

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Trivalent M-related protein as ...... roup A streptococcal vaccines.

@en

type

Item

label

Trivalent M-related protein as ...... roup A streptococcal vaccines.

@en

prefLabel

Trivalent M-related protein as ...... roup A streptococcal vaccines.

@en

P1476

Trivalent M-related protein as ...... roup A streptococcal vaccines.

@en

P2093

Adam Greeley

http://www.w3.org/2001/XMLSchema#string

Claudia M Hohn

http://www.w3.org/2001/XMLSchema#string

Harry S Courtney

http://www.w3.org/2001/XMLSchema#string

James B Dale

http://www.w3.org/2001/XMLSchema#string

Shannon E Niedermeyer

http://www.w3.org/2001/XMLSchema#string

Thomas A Penfound

http://www.w3.org/2001/XMLSchema#string

P2860

Non-immune binding of human IgG to M-related proteins confers resistance to phagocytosis of group A streptococci in blood.

The global burden of group A streptococcal diseases.

Group A streptococcus expresses a trio of surface proteins containing protective epitopes.

Protective immunogenicity of group A streptococcal M-related proteins.

New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci

Global emm type distribution of group A streptococci: systematic review and implications for vaccine development.

Potential coverage of a multivalent M protein-based group A streptococcal vaccine.

Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers.

Differentiation of group A streptococci with a common R antigen into three serological types, with special reference to the bactericidal test

Promotion of phagocytosis of Streptococcus pyogenes in human blood by a fibrinogen-binding peptide.

P304

45-49

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7774/CEVR.2017.6.1.45

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

James B Dale

Harry S Courtney

Shannon E Niedermeyer

Thomas A Penfound

Claudia M Hohn

Adam Greeley

P577

2017-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28168173

http://www.w3.org/2001/XMLSchema#string

P932

5292357

http://www.w3.org/2001/XMLSchema#string

Trivalent M-related protein as a component of next generation group A streptococcal vaccines.

about

P2860

P2860

Trivalent M-related protein as a component of next generation group A streptococcal vaccines.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932